Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Titel:
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Auteur:
Ashina, Messoud Tepper, Stewart Brandes, Jan Lewis Reuter, Uwe Boudreau, Guy Dolezil, David Cheng, Sunfa Zhang, Feng Lenz, Robert Klatt, Jan Mikol, Daniel D